CIK 0001817229 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Vor Biopharma Inc.
Sign in to watch- Ticker
- VOR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 811591163
- Phone
- 617-655-6580
- Business address
- 500 BOYLSTON STREET, SUITE 1350, BOSTON, MA, 02116
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-12-30 | Reprogrammed Interchange LLC 10% owner | Purchase | +38,974,101 | 38,974,101 | ||
| 2021-02-09 | 5AM Ventures VI, L.P. 10% owner | Purchase | +111,111 | $18.00 | $2.0M | 4,833,959 |
| 2021-02-09 | 5AM Ventures VI, L.P. 10% owner | Purchase | +444,444 | $18.00 | $8.0M | 1,858,470 |
| 2021-02-09 | PARMAR KUSH Director | Purchase | +111,111 | $18.00 | $2.0M | 4,833,959 |
| 2021-02-09 | PARMAR KUSH Director | Purchase | +444,444 | $18.00 | $8.0M | 1,858,470 |
| 2021-02-09 | RA CAPITAL MANAGEMENT, L.P. Director | Purchase | +2,848,596 | $18.00 | $51.3M | 8,297,265 |
| 2021-02-09 | RA CAPITAL MANAGEMENT, L.P. Director | Purchase | +130,970 | $18.00 | $2.4M | 1,825,326 |
Page 1 of 1 · 7 trades